Clinical Trials Browser

INDUSTRY × Breast Neoplasms × LY3295668 erbumine × Clear all

NCT03092934 2021-07-02

A Study of AK-01 (LY3295668) in Solid Tumors

Phase 1/2 Completed

13 enrolled 17 charts

BreastHead & NeckThoracic

Breast Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03955939 2020-06-01

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

Phase 1 Completed

Breast Neoplasms, Epilepsy